Endometrial polyp (EP) is a benign uterine lesion that forms as a result of the protrusion of the endometrial gland, stroma, and blood vessels into the uterine cavity due to hyperplasia. EP is benign and may resolve spontaneously, but in rare cases, it may exhibit malignant effects. The prevalence of EP is not yet known with certainty worldwide, but studies in the literature indicate that it accounts for 50% of abnormal uterine bleeding, 15-50% of recurrent spontaneous abortion cases, and 35% of infertility cases. EP frequently presents with symptoms such as abnormal uterine bleeding, infertility, pelvic pain, spotting after intercourse, and postmenopausal vaginal bleeding. It can also persist without presenting any symptoms. Age, family history, diabetes, hypertension, obesity, early spontaneous abortion, hyperoestrogenism, and Tamoxifen use are known risk factors for EP. Transvaginal ultrasonography (TVUSG), sonohysterography, computed tomography, and magnetic resonance imaging are used in the diagnosis of EP. Treatment options include conservative, non-surgical treatment, conservative surgery, or radical surgery. However, the basic standard in the diagnosis and treatment of EP is hysteroscopic endometrial polypectomy. The greatest advantage of hysteroscopy is that polyps can be resected at the same time as they are visualised. For this reason, it is currently a frequently preferred method of both diagnosis and treatment by gynaecologists. Due to the potential for EP to cause infertility, abnormal uterine bleeding, and, although possible, malignancy, it negatively affects both women’s reproductive capacity and quality of life. Therefore, it is important for nurses, who are key healthcare professionals, to educate and counsel women about the current/potential risk factors of EP, the likelihood of recurrence, modifiable factors, treatment options, alternatives, and outcomes.